Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's Disease Including Focal Presentations
Nicolas Villain, Bruno Dubois
Seminars in Neurology (2019) Vol. 39, Iss. 02, pp. 213-226
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 690
The complexity of Alzheimer’s disease: an evolving puzzle
Camilla Ferrari, Sandro Sorbi
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1047-1081
Closed Access | Times Cited: 207
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Bruno Dubois, Christine A. F. Von Arnim, Nerida Burnie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 85
Depression as a Risk Factor for Alzheimer’s Disease: A Systematic Review of Longitudinal Meta-Analyses
Olalla Sáiz-Vazquez, Patricia Gracia‐García, Silvia Ubillos Landa, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1809-1809
Open Access | Times Cited: 95
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 86
Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer’s disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway
Sha Sha, Xueli Shen, Yunpeng Cao, et al.
Aging (2021)
Open Access | Times Cited: 63
Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases
Roberto Bonanni, Ida Cariati, Umberto Tarantino, et al.
Journal of Functional Morphology and Kinesiology (2022) Vol. 7, Iss. 2, pp. 38-38
Open Access | Times Cited: 55
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease
Honghua Zhang, Yuying Wang, Yuqing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114606-114606
Closed Access | Times Cited: 55
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review
Hannah W. Haddad, Garett W. Malone, Nicholas J. Comardelle, et al.
Health psychology research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Rajeev Taliyan, Violina Kakoty, K C Sarathlal, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 528-550
Closed Access | Times Cited: 45
An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases
Xuan Wei, Guangshan Huang, Jiyong Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114619-114619
Open Access | Times Cited: 23
A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET
Antoine Rogeau, Florent Hives, Cécile Bordier, et al.
NeuroImage (2024) Vol. 288, pp. 120530-120530
Open Access | Times Cited: 11
NLRP3 inflammasome in health and disease (Review)
Haoran Wang, Li Ma, Weiran Su, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access | Times Cited: 1
The Risk of Developing Alzheimer’s Disease and Parkinson’s Disease in Patients with Inflammatory Bowel Disease: A Meta-Analysis
Marta Szandruk-Bender, Benita Wiatrak, Adam Szeląg
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3704-3704
Open Access | Times Cited: 35
Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics
Jing Lu, Xian Wang, Anxin Wu, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 4, pp. 1523-1544
Closed Access | Times Cited: 32
JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer’s disease
Chiara Scopa, Samantha M. Barnada, M.E. Cicardi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Neutrophil Extracellular Traps in Cerebral Ischemia/Reperfusion Injury: Friend and Foe
Haoyue Luo, Hanjing Guo, Yue Zhou, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 10, pp. 2079-2096
Open Access | Times Cited: 17
YAP in development and disease: Navigating the regulatory landscape from retina to brain
Yaqin Zhao, Bin Sun, Xuefei Fu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116703-116703
Open Access | Times Cited: 7
β-Amyloid peptide modulates peripheral immune responses and neuroinflammation in rats
Krishnendu Adhikary, Satyajit Mohanty, Bidyut Bandyopadhyay, et al.
BioMolecular Concepts (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Metabolic and Immune System Dysregulation: Unraveling the Connections between Alzheimer’s Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis
Julia Doroszkiewicz, Jan Mroczko, Izabela Winkel, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5057-5057
Open Access | Times Cited: 6
The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease
Heather H. C. Lau, Martin Ingelsson, Joel C. Watts
Acta Neuropathologica (2020) Vol. 142, Iss. 1, pp. 17-39
Closed Access | Times Cited: 49
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
G. Bellomo, Antonio Indaco, Davide Chiasserini, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 33
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders
Маргарита Е. Неганова, Yulia Aleksandrova, Olga Sukocheva, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 805-833
Closed Access | Times Cited: 28
Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer’s disease
Lijie He, Zongnan Chen, Jing Wang, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 23
MDSVDNV: predicting microbe–drug associations by singular value decomposition and Node2vec
Huilin Tan, Zhen Zhang, Xin Liu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top